Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis

被引:0
|
作者
Paul Harasymowycz
Cindy Hutnik
Jean-François Rouland
Francisco J. Muñoz Negrete
Mario A. Economou
Philippe Denis
Christophe Baudouin
机构
[1] University of Montreal,Ivey Eye Institute
[2] Bellevue Ophthalmology Clinics and Montreal Glaucoma Institute,Ophthalmology Department
[3] Western University,Department of Ophthalmology
[4] University of Lille,undefined
[5] Hospital Ramón y Cajal,undefined
[6] Universidad Alcalá,undefined
[7] Ophthalmology,undefined
[8] Queen Sofia Hospital,undefined
[9] Praktikertjänst,undefined
[10] HEH,undefined
[11] Hospices Civils de Lyon,undefined
[12] Quinze-Vingts National Ophthalmology Hospital,undefined
来源
Advances in Therapy | 2021年 / 38卷
关键词
Open-angle glaucoma; Ocular hypertension; Hyperemia; Ocular surface disease; Intraocular pressure; Latanoprost; Preservative-free; Monoprost; Patient satisfaction;
D O I
暂无
中图分类号
学科分类号
摘要
Preservatives in eye drops for glaucoma can cause side effects such as stinging and eye redness. These side effects can cause some patients to reduce the frequency of the drops as prescribed or stop using the drops. One of the most common drops for glaucoma is latanoprost. This study evaluated whether a preservative-free latanoprost (PFL) is as effective as preservative-containing latanoprost (PCL) for reducing eye pressure and whether PFL is better tolerated in patients with glaucoma. The results of the study indicated that PFL was as effective as PCL for reducing eye pressure. The results also indicated PFL was much better at reducing the side effects related to PCL. For example PFL reduces eye redness up to twofold compared to PCL. By reducing the side effects associated with PCL patients may continue to take their glaucoma drops as directed and thereby reduce the risk of vision loss from glaucoma.
引用
收藏
页码:3019 / 3031
页数:12
相关论文
共 50 条
  • [1] Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
    Harasymowycz, Paul
    Hutnik, Cindy
    Rouland, Jean-Francois
    Negrete, Francisco J. Munoz
    Economou, Mario A.
    Denis, Philippe
    Baudouin, Christophe
    ADVANCES IN THERAPY, 2021, 38 (06) : 3019 - 3031
  • [2] Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension
    Aptel, Florent
    Choudhry, Reena
    Stalmans, Ingeborg
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (08) : 1457 - 1463
  • [3] HEALTH ECONOMIC EVALUATION OF PRESERVATIVE-FREE TAFLUPROST VERSUS PRESERVED LATANOPROST IN THE TREATMENT OF OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION (OH)
    Makino, K.
    Charles, H.
    Tilden, D.
    Cottrell, S.
    Mudge, M.
    Christova, L.
    Van Bavel, J.
    West, B.
    Woodgate, A. M.
    VALUE IN HEALTH, 2012, 15 (07) : A643 - A643
  • [4] The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
    Misiuk-Hojlo, Marta
    Pomorska, Maria
    Mulak, Malgorzata
    Rekas, Marek
    Wierzbowska, Joanna
    Prost, Marek
    Wasyluk, Jaromir
    Lubinski, Wojciech
    Podboraczynska-Jodko, Karolina
    Romaniuk, Wanda
    Kinasz, Renata
    Ortyl-Markiewicz, Renata
    Mocko, Lucyna
    Zaleska-Zmijewska, Anna
    Rokicki, Dariusz
    Baudouin, Christophe
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (02) : 210 - 215
  • [5] Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma
    Rouland, Jean-Francois
    Traverso, Carlo Enrico
    Stalmans, Ingeborg
    El Fekih, Lamia
    Delval, Laurent
    Renault, Didier
    Baudouin, Christophe
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (02) : 196 - 200
  • [6] Comparing the tolerability of preservative-free tafluprost versus preserved latanoprost in the management of glaucoma and ocular hypertension - an observer blinded active-control trial
    Brinkman, David
    McSwiney, Terence
    James, Mark
    IRISH JOURNAL OF MEDICAL SCIENCE, 2024, 193 (05) : 2589 - 2595
  • [7] A phase III study comparing preservative-free latanoprost eye drop emulsion with preserved latanoprost in open-angle glaucoma or ocular hypertension
    Baudouin, Christophe
    Stalmans, Ingeborg
    Bourne, Rupert
    Larrosa, Jose Manuel
    Schmickler, Stefanie
    Seleznev, Aleksey
    Oddone, Francesco
    Phase III Study Group, Yosuf
    EYE, 2025,
  • [8] Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension
    Carl Erb
    Ines Lanzl
    Seid-Fatima Seidova
    Friedemann Kimmich
    Advances in Therapy, 2011, 28
  • [9] Efficacy and patient tolerability of preservative-free latanoprost compared with preservative prostaglandin analogs in patients with ocular hypertension or glaucoma
    El Ameen, A.
    Vandermeer, G.
    Pisella, P. J.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [10] A REVIEW OF PRESERVED AND PRESERVATIVE-FREE PROSTAGLANDIN ANALOGUES FOR THE TREATMENT OF OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION
    Hommer, A.
    DRUGS OF TODAY, 2010, 46 (06) : 409 - 416